CLDF Title
Contact Us | Bookmark
HBV HCC HCV HE NASH PBC
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
REFILE-Treating HCV may improve glycemic control in diabetics
07-20-2017
Treating HCV may improve glycemic control in diabetics
07-19-2017
FDA approves Gilead's drug for chronic hep C patients
07-18-2017
Endoscopic ultrasound accurately detects bile duct stones
07-05-2017
Sustained response to direct-acting HCV antivirals tied to lower HCC risk
06-30-2017
View Complete News Library
 
 
September 15-17
11th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Seoul, South Korea
October 20-24
AASLD 2017
Washington, DC
October 28 - Nov 1
25TH UEG Week 2017
Barcelona, Spain
View all Congresses
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study
 
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010
 
Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C
 
Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy
 
Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'
 
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
 
 
Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden
 
Treatment of chronic hepatitis B infection-2017
 
Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
 
Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis
 
A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis
 
Optimal treatment of hepatic encephalopathy
 
 
Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis
 
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study
 
Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma
 
Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database
 
Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions
 
Treatment of Non-Alcoholic Fatty Liver Disease
 
 
          View All Abstracts  
  Line  
                         
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.